ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)
Clinical trial NCT00439192 · TERMINATED
Trial details
- NCT number
- NCT00439192
- Sponsor
- elbion AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.